Skip to content

Public FDA record

Z-0219-2024: LeadCare II Blood Lead Test Kit-For in vitro diagnostic use only. The test kit is for the quantitative me

Recall record Z-0219-2024 for Magellan Diagnostics, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0219-2024
Company in FDA record
Magellan Diagnostics, Inc.
FDA classification date
Nov 3, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

During an internal audit a small percentage (<10%) of plastic caps used to close the treatment reagent tubes were found to not meet the minimum dimensional lip requirement and may have inadequate cap-to-tube seals. Manufacturing with these caps may result in cap-to-tube seals that allow leaking of HCl or may result in cap-to-tube seals that allow evaporation of treatment reagent. The consequence of this would be a change in the volume of treatment reagent and a change in the ratios of either added patient sample or control material to treatment reagent. The result of this might be a falsely elevated result (e.g., a patient false positive [PATFP] result or a Controls Out of Range-High [COOR-Hi] result).

Source facts

Action
Magellan notified distributors/end users. Distributors initially contacted 19 September 2023 and told they would receive additional contacts from Magellan related to the recall and requests for a formal response. All distributors contacted by phone and provided the Recall Response forms included in the Recall Notification Letters. Hard copy recall notification letters issued via mail on Sept. 22, 2023. Distributors requested to provide customer lists and notifications will be carried out to the user level. Distributors will be permitted to continue distribution of impacted product, and users will be instructed to continue to use impacted product; however, replacement product will be provided upon request or if a consignee complains of PATFP or COOR-Hi results. The recall letter states reason for recall, health risk and action to take: Review current inventory and identify any remaining unexpired stock impacted by this recall: MAGELLAN WILL REPLACE IMPACTED PRODUCT UPON REQUEST; HOWEVER,YOU MAY CONTINUE TO USE ANY REMAINING UNEXPIRED STOCK. Continue to monitor impacted product for Controls Out of Range-High (COOR-Hi) results. If after following instructions in the LeadCare II Users Guide the control value is still out of range, please contact Magellan Technical Support. If you observe an elevated blood lead result on a patient, the test results should be shared with the patients physician for interpretation and to determine when retesting and follow-up care are necessary. If you identify a PATFP or a COOR-Hi result, you can contact Magellan Technical Support at 1-800-275-0102 to obtain a FedEx label to return any product to Magellan Diagnostics, Inc. and receive replacement product. Product will be replaced based on availability, and on a first-come first-served basis. NO ADDITIONAL ACTION IS REQUIRED: It is the recommendation of the Centers for Disease Control and Prevention (CDC) that if an initial blood lead screening is above the Blood Lead Reference Valu
Initiated
2023-09-19
Root cause
Nonconforming Material/Component
Distribution
US Nationwide distribution.
Recall number
Z-0219-2024
Recall status
Open, Classified
CDRH record ID
203593
FDA classified
2023-11-03
Recall event number
93167

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗